Skip to content
10-Q

Quarterly Report

Odonate Therapeutics, Inc.

0001564590-20-048168

← back to feed
Filed
Oct 28, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2020 · Oct 14, 2020 38.53M sh
Stock Issued Q3 2020 · Sep 30, 2020 842.11K sh
Stock Issued Q3 2020 · Sep 1, 2020 5.61M sh
Stock Issued Q3 2020 · Jul 2, 2019 712.5K sh
Stock Issued Q3 2020 · Jun 28, 2019 4.75M sh
Current Liabilities Q3 2020 · Sep 30, 2020 $28.54M
Current Liabilities Q3 2020 · Dec 31, 2019 $24.78M
Total Liabilities Q3 2020 · Sep 30, 2020 $33.39M
Total Liabilities Q3 2020 · Dec 31, 2019 $26.53M
Current Assets Q3 2020 · Sep 30, 2020 $190.73M
Current Assets Q3 2020 · Dec 31, 2019 $183.93M
Total Assets Q3 2020 · Sep 30, 2020 $198.99M
Total Assets Q3 2020 · Dec 31, 2019 $188.83M
Capex Q3 2020 · Sep 30, 2019 $164K
Operating Cash Flow Q3 2020 · Sep 30, 2019 −$72.12M
Cash And Equivalents Q3 2020 · Sep 30, 2019 $204.5M
Cash And Equivalents Q3 2020 · Dec 31, 2018 $139.3M
Stockholders Equity Q3 2020 · Sep 30, 2019 $186.2M
Stockholders Equity Q3 2020 · Jun 30, 2019 $190.86M
Stockholders Equity Q3 2020 · Mar 31, 2019 $98.44M
Stockholders Equity Q3 2020 · Dec 31, 2018 $124M
Sga Expense Q3 2020 · Sep 30, 2019 $2.67M
Sga Expense Q3 2020 · Sep 30, 2019 $8.04M
Rd Expense Q3 2020 · Sep 30, 2019 $25.1M
Rd Expense Q3 2020 · Sep 30, 2019 $78.18M
Net Income Q3 2020 · Sep 30, 2019 −$26.63M
Net Income Q3 2020 · Sep 30, 2019 −$83.97M
Net Income Q3 2020 · Jun 30, 2019 −$28.7M
Net Income Q3 2020 · Mar 31, 2019 −$28.65M
Operating Income Q3 2020 · Sep 30, 2019 −$27.76M
Operating Income Q3 2020 · Sep 30, 2019 −$86.22M